Comments
Pharma major Lupin today said it has received approval from the UK health regulator for its Goa facility. Lupin in a regulatory filing said, “it has received approval from UK MHRA (United Kingdom’s Medicines and Healthcare Products Regulatory Agency) for its Goa facility.
The unit was inspected by UK MHRA in March 2018 and there were no critical or major observations cited, it added. Shares of Lupin were trading 2.35 per cent lower at Rs 844.90 on BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.